5x smartscribe rt buffer (TaKaRa)
TaKaRa is a verified supplier 
TaKaRa manufactures this product 
96
Structured Review
TaKaRa
5x smartscribe rt buffer
5x Smartscribe Rt Buffer, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1142 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5x+rt-buffer/SMARTScribe+Reverse+Transcriptase/pmc12159498-435-66-76
Average 96 stars, based on 1142 article reviews
5x Smartscribe Rt Buffer, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1142 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5x+rt-buffer/SMARTScribe+Reverse+Transcriptase/pmc12159498-435-66-76
Average 96 stars, based on 1142 article reviews
5x smartscribe rt buffer - by Bioz Stars,
2026-11
96/100 stars
Images
Related Articles
Reverse Transcription:Article Title: m 6 A/YTHDF2-mediated mRNA decay targets TGF-β signaling to suppress the quiescence acquisition of early postnatal mouse hippocampal NSCs. Article Snippet: In brief Zhang et al. revealed a distinct mode of epitranscriptomic control, with convergent co-regulation of multiple components of the same signaling pathway in stem cells.. Specifically, mA/YTHDF2 signaling promotes mRNA decay of multiple TGF-b pathway components, which reduces TGFb-signaling activation cell autonomously in proliferating neural stem cells to suppress their quiescence acquisition. Article Title: Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer's disease-associated proteopathology. Article Snippet: .. Then the mixture containing 0.5 μL of 100mM DTT, 0.3 μL of 200mM MgCl2, 1 μL of 10mM dNTPs, 0.25 μL RNase inhibitor, 1 μL of 10 μM TSO primer (5’-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3’), 2 μL of Article Title: Targeting G9a-m 6 A translational mechanism of SARS-CoV-2 pathogenesis for multifaceted therapeutics of COVID-19 and its sequalae Article Snippet: At 72 h post-treatment, 4 μL of Cell Counting Kit-8 (CCK-8; Sigma-Aldrich) was added to each well. .. For first strand cDNA synthesis, the mRNA was mixed with 0.25 μL RNase inhibitor and 1 μL CDS primer (5′-AAGCAGTGGTATCAACGCAGAGTACT30VN-3′) and heated to 70°C for 2 min. Then the mixture containing 0.5 μL of 100 mM DTT, 0.3 μL of 200 mM MgCl 2 , 1 μL of 10 mM dNTPs, 0.25 μL RNase inhibitor, 1 μL of 10 μM TSO primer (5′-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3′), 2 μL of Article Title: Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer’s disease-associated proteopathology Article Snippet: .. For first strand cDNA synthesis, the mRNA was mixed with 0.25 μL RNase inhibitor and 1 μL CDS primer (5’-AAGCAGTGGTATCAACGCAGAGTACT30VN-3’) and heated to 70 o C for 2 min. Then the mixture containing 0.5 μL of 100 mM DTT, 0.3 μL of 200 mM MgCl 2 , 1 μL of 10 mM dNTPs, 0.25 μL RNase inhibitor, 1 μL of 10 μM TSO primer (5’-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3’), 2 μL of Article Title: Non-canonical function of histone methyltransferase G9a in the translational regulation of chronic inflammation. Article Snippet: In brief Muneer et al. reveal that G9a—a histone methyltransferase and well-established transcriptional repressor—promotes macrophage proliferation, T cell depletion/dysfunction (lymphopenia), and organ-damaging ‘‘cytokine storm’’ (hyperinflammation) through its noncanonical/non-epigenetic function involving protein translation, a mechanism that can be leveraged to treat chronic inflammatory diseases including sepsis, ARDS, & COVID19. Article Title: Targeting G9a translational mechanism of SARS-CoV-2 pathogenesis for multifaceted therapeutics of COVID-19 and its sequalae Article Snippet: .. For first strand cDNA synthesis, the mRNA was mixed with 0.25 μL RNase inhibitor and 1 μL CDS primer (5’-AAGCAGTGGTATCAACGCAGAGTACT30VN-3’) and heated to 70 °C for 2 min. Then the mixture containing 0.5 μL of 100 mM DTT, 0.3 μL of 200 mM MgCl 2 , 1 μL of 10 mM dNTPs, 0.25 μL RNase inhibitor, 1 μL of 10 μM TSO primer (5’-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3’), 2 μL of Article Title: Epitranscriptomic regulation of cortical neurogenesis via Mettl8-dependent mitochondrial tRNA m 3 C modification. Article Snippet: Then, 2 mL of 5x SMARTScribe RT Buffer (TaKaRa), 0.5 mL of DTT (100 mM), 0.3 mL of MgCl2 (200 mM), 1 mL of dNTPs (10 mM), 1 mL of TSO primer (10 mM, 50-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-30), 0.25 mL of RNase inhibitor (NEB), and 0.5 mL SMARTScribe reverse transcriptase (TaKaRa) was added. .. Then, 2 mL of cDNA Synthesis:Article Title: Targeting G9a-m 6 A translational mechanism of SARS-CoV-2 pathogenesis for multifaceted therapeutics of COVID-19 and its sequalae Article Snippet: At 72 h post-treatment, 4 μL of Cell Counting Kit-8 (CCK-8; Sigma-Aldrich) was added to each well. .. For first strand cDNA synthesis, the mRNA was mixed with 0.25 μL RNase inhibitor and 1 μL CDS primer (5′-AAGCAGTGGTATCAACGCAGAGTACT30VN-3′) and heated to 70°C for 2 min. Then the mixture containing 0.5 μL of 100 mM DTT, 0.3 μL of 200 mM MgCl 2 , 1 μL of 10 mM dNTPs, 0.25 μL RNase inhibitor, 1 μL of 10 μM TSO primer (5′-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3′), 2 μL of Article Title: Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer’s disease-associated proteopathology Article Snippet: .. For first strand cDNA synthesis, the mRNA was mixed with 0.25 μL RNase inhibitor and 1 μL CDS primer (5’-AAGCAGTGGTATCAACGCAGAGTACT30VN-3’) and heated to 70 o C for 2 min. Then the mixture containing 0.5 μL of 100 mM DTT, 0.3 μL of 200 mM MgCl 2 , 1 μL of 10 mM dNTPs, 0.25 μL RNase inhibitor, 1 μL of 10 μM TSO primer (5’-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3’), 2 μL of Article Title: Targeting G9a translational mechanism of SARS-CoV-2 pathogenesis for multifaceted therapeutics of COVID-19 and its sequalae Article Snippet: .. For first strand cDNA synthesis, the mRNA was mixed with 0.25 μL RNase inhibitor and 1 μL CDS primer (5’-AAGCAGTGGTATCAACGCAGAGTACT30VN-3’) and heated to 70 °C for 2 min. Then the mixture containing 0.5 μL of 100 mM DTT, 0.3 μL of 200 mM MgCl 2 , 1 μL of 10 mM dNTPs, 0.25 μL RNase inhibitor, 1 μL of 10 μM TSO primer (5’-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3’), 2 μL of Synthesized:Article Title: CCHamide2-receptor regulates feeding behavior in the pea aphid, Acyrthosiphon pisum. Article Snippet: Neuropeptide CCHamide-2 is a recently discovered peptide presents in many arthropods and it is the ligand of the CCHamide-2 receptor (CCHa2-R), which is playing a regulatory role in diverse physiological processes, such as feeding, insulin production, lipid metabolism, growth and reproduction, however, the function of this gene in aphids is still unknown.. Here, we characterized and determined the presumed role of CCHa2-R signaling in the wingless pea aphid, Acyrthosiphon pisum.. Quantitative real-time reverse transcription-PCR (qRT-PCR) revealed the expression levels of CCHa2-R transcripts in different development stages and different tissues, which indicates that the CCHa2-R expression was high in the first instar as compared to the upcoming nymphal instars and adult and was predominantly high in the brain. RNA Sequencing:Article Title: Non-canonical function of histone methyltransferase G9a in the translational regulation of chronic inflammation. Article Snippet: In brief Muneer et al. reveal that G9a—a histone methyltransferase and well-established transcriptional repressor—promotes macrophage proliferation, T cell depletion/dysfunction (lymphopenia), and organ-damaging ‘‘cytokine storm’’ (hyperinflammation) through its noncanonical/non-epigenetic function involving protein translation, a mechanism that can be leveraged to treat chronic inflammatory diseases including sepsis, ARDS, & COVID19. |